Department of Urology, The First People's Hospital of Huzhou, The First Affiliated Hospital of Huzhou Teachers College, No. 158, Guangchanghou Road, Huzhou, 313000, Zhejiang, China.
Int Urol Nephrol. 2020 Jan;52(1):41-49. doi: 10.1007/s11255-019-02296-x. Epub 2019 Sep 27.
The purpose of this study was to analyze long-term complications, urodynamics, and quality of life (QoL) of patients after orthotopic ileal neobladder with orthotopic ureteral reimplantation to enrich clinical data and provide a basis for clinical use of this surgery.
Between January 2007 and January 2013, 72 consecutive patients who underwent spiral ileal neobladder following radical cystectomy were enrolled. The neobladder was created using a modified Camey-II technique. Complications were reviewed and staged according to Clavien-Dindo classification and evaluated in long-term follow-up. Urodynamics were performed, and QoL was assessed by the Functional Assessment of Cancer Therapy for Bladder Cancer (FACT-BL) instrument.
The total follow-up time was 60 months, and the total survival rates at 3 and 5 years after surgery were 76.4% (55/72) and 65.3% (47/72), respectively. There were 34 (47.2%) early complications in 23 (31.9%) patients and 42 (58.3%) late complications in 35 (48.6%) patients. The total satisfactory control rates were 69.1% and 66.0% at 3 and 5 years after the surgery, respectively. Urodynamic studies were performed in some patients, and the receiver operating characteristic curve analysis showed that pressure at maximum capacity, compliance, and post void residual urine had predictive value for mortality (P < 0.05). The total FACT-BL scores of patients at 1, 3, and 5 years postoperation were 125.0 ± 15.2, 127.0 ± 16.2, and 120.6 ± 13.5, respectively, and it decreased at 5 years postoperation (P < 0.05).
Spiral ileal neobladder with orthotopic ureteral reimplantation offers satisfactory long-term results, and urodynamic monitoring might have prognostic value.
本研究旨在分析经根治性膀胱切除术后行原位回肠代膀胱加输尿管原位再植患者的长期并发症、尿动力学和生活质量(QoL),以丰富临床数据并为该手术的临床应用提供依据。
2007 年 1 月至 2013 年 1 月,连续纳入 72 例行根治性膀胱切除术后行螺旋回肠代膀胱的患者。采用改良的 Camey-II 技术构建新膀胱。根据 Clavien-Dindo 分级对并发症进行回顾和分期,并在长期随访中进行评估。进行尿动力学检查,采用膀胱癌患者生活质量功能评估量表(FACT-BL)评估 QoL。
总随访时间为 60 个月,术后 3 年和 5 年的总生存率分别为 76.4%(55/72)和 65.3%(47/72)。23 例(31.9%)患者中有 34 例(47.2%)发生早期并发症,35 例(48.6%)患者中有 42 例(58.3%)发生晚期并发症。术后 3 年和 5 年的总满意控制率分别为 69.1%和 66.0%。对部分患者进行了尿动力学研究,受试者工作特征曲线分析显示,最大容量时压力、顺应性和残余尿量对死亡率有预测价值(P<0.05)。术后 1、3 和 5 年患者的 FACT-BL 总分分别为 125.0±15.2、127.0±16.2 和 120.6±13.5,术后 5 年时下降(P<0.05)。
螺旋回肠代膀胱加输尿管原位再植可获得满意的长期效果,尿动力学监测可能具有预后价值。